List of Excipients in API tavaborole
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing tavaborole
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| PharmaDerm A division of Fougera Pharmaceuticals Inc | KERYDIN | tavaborole | 10337-905 | ALCOHOL | |
| PharmaDerm A division of Fougera Pharmaceuticals Inc | KERYDIN | tavaborole | 10337-905 | EDETATE CALCIUM DISODIUM | |
| PharmaDerm A division of Fougera Pharmaceuticals Inc | KERYDIN | tavaborole | 10337-905 | PROPYLENE GLYCOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing tavaborole
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Padagis US LLC | tavaborole | 0574-0157 | ALCOHOL |
| Padagis US LLC | tavaborole | 0574-0157 | EDETATE CALCIUM DISODIUM |
| Padagis US LLC | tavaborole | 0574-0157 | PROPYLENE GLYCOL |
| Alembic Pharmaceuticals Limited | tavaborole | 46708-467 | ALCOHOL |
| Alembic Pharmaceuticals Limited | tavaborole | 46708-467 | EDETATE CALCIUM DISODIUM |
| Alembic Pharmaceuticals Limited | tavaborole | 46708-467 | PROPYLENE GLYCOL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for tavaborole
Excipient focus: ALCOHOL
tavaborole drug variants containing ALCOHOL
tavaborole drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE CALCIUM DISODIUM
tavaborole drug variants containing EDETATE CALCIUM DISODIUM
tavaborole drug variants not containing EDETATE CALCIUM DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
tavaborole drug variants containing PROPYLENE GLYCOL
tavaborole drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
tavaborole drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Chartwell RX LLC | tavaborole | 62135-663 |
| >Company | >Ingredient | >NDC |
tavaborole drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch